<DOC>
	<DOCNO>NCT02016625</DOCNO>
	<brief_summary>The primary objective trial investigate effect multiple-dose faldaprevir ( FDV ) single-dose pharmacokinetics cyclosporine tacrolimus</brief_summary>
	<brief_title>Investigation Potential Drug-drug Interactions Between Faldaprevir Immunosuppressant Drugs Cyclosporine Tacrolimus</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion criterion : Healthy male females subject Age 18 50 year ( incl . ) Body mass index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Signed date write informed consent prior admission study Exclusion criterion : Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal judge clinically relevant investigator . Systolic blood pressure ( BP ) less 100 mmHg 140 mmHg . Diastolic BP le 60 mmHg 90 mmHg . Pulse rate ( PR ) less 50 bpm 90 bpm . Any laboratory value outside reference range investigator considers clinical relevance Any evidence concomitant disease judge clinically relevant investigator Positive QuantiFERONTB Gold InTube</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>